Skip to content

Comparison of the effect of epinephrine in combination with methylprednisolone on neurological complications in patients with cardiopulmonary arrest

Comparison of the effect of epinephrine in combination with methylprednisolone on neurological complications and the need for vasopressor after resuscitation in patients with cardiopulmonary arrest

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130812014333N127
Enrollment
342
Registered
2019-07-27
Start date
2019-05-15
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary arrest. Cardiac arrest

Interventions

Intervention 1: The intervention group, in addition to receiving one mg of epinephrine, in each respiratory resuscitation cycle, every 3 to 5 minutes later will received125 mg intravenous methylpredn

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Above 18 years old No previous neurological disorders Cardiopulmonary arrest

Exclusion criteria

Exclusion criteria: Patients who do not have the possibility of injections during recovery due to the lack of peripheral blood vessels Patients with cardiopulmonary arrest outside the hospital

Design outcomes

Primary

MeasureTime frame
Neurological complications. Timepoint: 24 hours after resuscitation. Method of measurement: Based on a doctor's Checking out and according to Cerebral performance category.;Hypertension. Timepoint: 24 hours after resuscitation. Method of measurement: Using Digital Blood Pressure.;Rhythm during resuscitation. Timepoint: 24 hours after resuscitation. Method of measurement: Using a heart rhythm monitoring device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Bahrami

Kermanshah University of Medical Sciences

Rejimdarmani@yahoo.com+98 83 3427 6330

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026